Isis Pharmaceuticals Private Limited
About Isis Pharmaceuticals Private Limited
Data last updated:
Isis Pharmaceuticals Private Limited is a private limited company based in Harnana, Haryana, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 10 May 2002 and has been in existence for over 24 years.
The company is registered with the Registrar of Companies (ROC), Haryana, under CIN U24231HR2002PTC034882. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Jitender Deewan and Lokesh Anand.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 10/69 Gali No 3 Indira Colony Ilqtr Hisar, Harnana, Haryana, India – 125001.
As per MCA filings, the company has open charges of ₹10 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Isis Pharmaceuticals Private Limited's registered office is in Harnana, Haryana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address10/69 Gali No 3 Indira Colony Ilqtr Hisar, Harnana, Haryana, India – 125001
- IndustryTrading, Other Wholesale, Wholesale
To see the full contact details of Isis Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Isis Pharmaceuticals Private Limited
FY 2024 filings availableIsis Pharmaceuticals Private Limited reported revenue of ₹6,600 (down 5% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 68% over five years, including a 5% fall in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Isis Pharmaceuticals Private Limited, buy the company report.
Board of directors of Isis Pharmaceuticals Private Limited
Isis Pharmaceuticals has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jitender Deewan Also directs: Mehtani Dsa Services Private Limited | Director | 10 May 2002 | 24 Years 5 Months | Current |
| Lokesh Anand | Director | 10 May 2002 | 24 Years 5 Months | Current |
| Sandeep Singh | Director | 14 May 2003 | 23 Years 5 Months | Current |
Auditor
Isis Pharmaceuticals Private Limited is audited by MEHTANI ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MEHTANI ASSOCIATES | FY 2017 | 016667N |
Shareholding
The shareholding of Isis Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Isis Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 23 Sep 2011 | 10314778 | Oriental Bank of Commerce | ₹10 Lakh | Open |
To see the full charge records of Isis Pharmaceuticals Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Isis Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Isis Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Isis Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Isis Pharmaceuticals Private Limited, buy the company report.
Recent activity
Isis Pharmaceuticals Private Limited has 3 board changes on record since 2002: 3 appointments. The latest: Sandeep Singh was appointed as Director on 14 May 2003.
Frequently asked questions
Isis Pharmaceuticals is an active private limited company based in Harnana, Haryana, India. The company works in other wholesale, within the trading industry. It was incorporated on 10 May 2002 (24+ years old) and is registered under CIN U24231HR2002PTC034882.
Isis Pharmaceuticals has 3 current directors:
- Jitender Deewan - Director
- Lokesh Anand - Director
- Sandeep Singh - Director
The latest financial statements of Isis Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
No. Isis Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Isis Pharmaceuticals is U24231HR2002PTC034882. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Isis Pharmaceuticals was incorporated on 10 May 2002, making it 24+ years old. It is registered with the Registrar of Companies, Haryana.
Sandeep Singh was appointed as Director on 14 May 2003. Jitender Deewan was appointed as Director on 10 May 2002. Lokesh Anand was appointed as Director on 10 May 2002.
The registered office of Isis Pharmaceuticals is at 1069 Gali No 3 Indira Colony Ilqtr Hisar, Harnana, Haryana, India – 125001.
Isis Pharmaceuticals operates in the trading industry, in the other wholesale segment.
Isis Pharmaceuticals has open charges of ₹10 Lakh and no satisfied charges on record as per latest MCA filings.